We are live on
!
Find out more
GIP
Granite Investment Partners Portfolio holdings
AUM
$1.95B
1-Year Est. Return
49.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.51%
1 Year Est. Return
+49.89%
3 Year Est. Return
+130.82%
5 Year Est. Return
+170.12%
10 Year Est. Return
+1,227.59%
AUM
$1.87B
AUM Growth
+$103M
(+5.8%)
Cap. Flow
+$19.6M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
16.23%
Holding
382
New
29
Increased
179
Reduced
125
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Core Laboratories
CLB
|
+$15.6M |
| 2 |
KEM
KEMET Corporation
KEM
|
+$13.4M |
| 3 |
Appian
APPN
|
+$13.1M |
| 4 |
Codexis
CDXS
|
+$10.9M |
| 5 |
LivePerson
LPSN
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$16.7M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$13.3M |
| 3 |
FIVE9
FIVN
|
+$12.2M |
| 4 |
EFII
Electronics for Imaging
EFII
|
+$9.96M |
| 5 |
CRAY
Cray, Inc.
CRAY
|
+$9.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 17.3% |
| 3 | Industrials | 16.63% |
| 4 | Financials | 9.74% |
| 5 | Consumer Discretionary | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Coca-Cola
KO
$375B
| $332K | 0.02% |
6,529
-318
| -5% | -$15.6K |
|
|
PVLA
302
Palvella Therapeutics
PVLA
$2.27B
| $331K | 0.02% |
880
-774
| -47% | -$231K |
|
|
YGYI
303
DELISTED
Youngevity International, Inc Common Stock
YGYI
| $329K | 0.02% |
57,754
-50,679
| -47% | -$292K |
|
|
VAPO
304
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $322K | 0.02% |
1,748
-3,410
| -66% | -$505K |
|
305
Zymeworks
ZYME
$1.73B
| $320K | 0.02% |
14,527
-12,750
| -47% | -$234K |
|
|
RDS.A
306
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $313K | 0.02% |
4,808
| – | – |
|
307
Comcast
CMCSA
$90B
| $305K | 0.02% |
7,202
+822
| +13% | +$34.7K |
|
308
Lakeland Industries
LAKE
$119M
| $303K | 0.02% |
27,081
-23,773
| -47% | -$287K |
|
|
CDK
309
DELISTED
CDK Global, Inc.
CDK
| $297K | 0.02% |
6,008
-3,264
| -35% | -$175K |
|
310
Lifecore Biomedical
LFCR
$190M
| $296K | 0.02% |
31,585
-27,634
| -47% | -$279K |
|
311
Acme United Corp
ACU
$213M
| $292K | 0.02% |
12,944
-11,359
| -47% | -$232K |
|
312
American Express
AXP
$230B
| $265K | 0.01% |
2,150
+50
| +2% | +$5.87K |
|
313
EOG Resources
EOG
$70.7B
| $265K | 0.01% |
2,846
-145
| -5% | -$13.5K |
|
314
SI-BONE Inc
SIBN
$834M
| $265K | 0.01% |
13,009
-32,142
| -71% | -$552K |
|
315
Universal Health Services
UHS
$10.5B
| $261K | 0.01% |
2,000
| – | – |
|
|
MRUS
316
DELISTED
Merus
MRUS
| $247K | 0.01% |
16,851
-14,794
| -47% | -$210K |
|
317
Vail Resorts
MTN
$5.3B
| $245K | 0.01% |
1,100
| – | – |
|
318
Neuronetics
STIM
$166M
| $233K | 0.01% |
18,622
-28,742
| -61% | -$406K |
|
319
Sherwin-Williams
SHW
$89.8B
| $229K | 0.01% |
1,500
| – | – |
|
320
LiqTech
LIQT
$21M
| $228K | 0.01% |
+2,867
| New | +$197K |
|
|
PCQ
321
Pimco California Municipal Income Fund
PCQ
$167M
| $226K | 0.01% |
12,108
| – | – |
|
|
GOLD
322
Gold.com Inc
GOLD
$1.26B
| $223K | 0.01% |
34,054
-29,524
| -46% | -$179K |
|
|
TBCH
323
Turtle Beach Corp
TBCH
$277M
| $221K | 0.01% |
+19,151
| New | +$203K |
|
324
International Flavors & Fragrances
IFF
$21.9B
| $218K | 0.01% |
+1,500
| New | +$208K |
|
325
Cytosorbents Corp
CTSO
$22.6M
| $214K | 0.01% |
32,359
-78,171
| -71% | -$537K |
|
Similar funds
FC
NIM
HA
BC
FFH
OCM
AAA
TCM
Granite Investment Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Granite Investment Partners held 382 positions worth $1.87B, up 5.8% from $1.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Granite Investment Partners's Q2 2019 filing shows 29 new, 179 increased, 125 reduced and 27 closed positions. Its largest new stake was Core Laboratories: 266,309 shares worth $13.9M. The largest sale was QTS REALTY TRUST, INC., an estimated $16.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.
- Granite Investment Partners's largest Q2 2019 buy was Core Laboratories: 266,309 shares worth $13.9M.
- Granite Investment Partners added most to LivePerson in Q2 2019, an estimated $10.8M increase.
- Granite Investment Partners's biggest Q2 2019 reduction was FIVE9, cutting an estimated $12.2M.
- Granite Investment Partners fully exited QTS REALTY TRUST, INC. in Q2 2019, selling an estimated $16.7M.
- Granite Investment Partners's ten largest holdings make up 16% of its $1.87B portfolio in Q2 2019.
- Granite Investment Partners opened 29 new positions and closed 27 in Q2 2019.
- Granite Investment Partners's portfolio value rose 5.8% quarter-over-quarter to $1.87B.
Based on Granite Investment Partners's 13F filing for Q2 2019, filed 7 Aug 2019.